The American Heart Association on Dec. 13 announced that it would be awarding more than $14 million in research grants to advance its new Strategically Focused Research Network on Cardiometabolic Health and Type 2 Diabetes.

An FDA-approved antiarrhythmic drug known as dofetilide could be repurposed to treat pulmonary arterial hypertension, researchers have found.

A study published in JACC suggests that, when combined with high-intensity statin therapy, evolocumab can be an effective tool for lowering LDL-cholesterol in patients who have experienced an acute coronary syndrome.

The FDA is testing metformin, a popular drug used to treat type 2 diabetes, for carcinogenic impurities.

A nine-week mindfulness training course helped hypertensive patients lower their blood pressure and improve healthy habits in a study out of the Mindfulness Center at Brown University’s School of Public Health.

A study presented at the American Heart Association’s Scientific Sessions in Philadelphia this November found that heart patients who practiced routine intermittent fasting over a period of four and a half years were ultimately healthier than those who didn’t.

Legal loopholes in the 510(k) clearance process mean countless faulty BP devices can make it to pharmacy shelves without proper testing, leading to confusion among consumers and healthcare providers alike, according to a news story from the American Medical Association.

Joint research from the American Heart Association and American Medical Association suggests that just half of practicing physicians and healthcare professionals have received blood pressure measurement training since they left school.